Latest filing published 31 May 2011 for Impax Laboratories, LLC, €16k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Charles Hildenbrand V: trading record in brief
Charles Hildenbrand V appears in our data through filings on Impax Laboratories, LLC shares, published by SEC (Form 4). In total, 6 filings cover trades dated from 13 March 2009 to 26 May 2011.
No open-market sale appears; the market trades are 1 purchase worth €22k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 5 share grants.
On 31 May 2011 came the latest disclosure, a share grant for €16k in Impax Laboratories, LLC. The last purchase on record was published on 16 March 2009, which is 6,447 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Charles Hildenbrand V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 826 shares@ US$26.76Common StockSEC:0001209191-11-031972:0
- 2,476 shares@ US$26.93Common StockSEC:0001209191-11-030819:0
- 9,000 shares0Common StockSEC:0001209191-10-031006:0
- 2,476 shares@ US$19.65Common StockSEC:0001209191-10-030126:0
- 27,000 shares0Common StockSEC:0001209191-09-028241:0
- 5,000 shares@ US$5.75Common StockSEC:0001209191-09-016376:0Canonical exit: 11 Jun 2009 (T+90)
6 of 6 declarations
